Does TECLISTAMAB-CQYV Cause Thrombocytopenia? 39 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 39 reports of Thrombocytopenia have been filed in association with TECLISTAMAB-CQYV. This represents 2.5% of all adverse event reports for TECLISTAMAB-CQYV.
39
Reports of Thrombocytopenia with TECLISTAMAB-CQYV
2.5%
of all TECLISTAMAB-CQYV reports
10
Deaths
13
Hospitalizations
How Dangerous Is Thrombocytopenia From TECLISTAMAB-CQYV?
Of the 39 reports, 10 (25.6%) resulted in death, 13 (33.3%) required hospitalization, and 2 (5.1%) were considered life-threatening.
Is Thrombocytopenia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TECLISTAMAB-CQYV. However, 39 reports have been filed with the FAERS database.
What Other Side Effects Does TECLISTAMAB-CQYV Cause?
Cytokine release syndrome (406)
Immune effector cell-associated neurotoxicity syndrome (153)
Off label use (122)
Death (116)
Plasma cell myeloma (96)
Infection (83)
Neutropenia (74)
Fatigue (72)
Pyrexia (67)
Covid-19 (64)
What Other Drugs Cause Thrombocytopenia?
DEXAMETHASONE (5,873)
RITUXIMAB (4,810)
CYCLOPHOSPHAMIDE (4,669)
LENALIDOMIDE (4,584)
CARBOPLATIN (4,483)
METHOTREXATE (3,865)
DOXORUBICIN (3,638)
ETOPOSIDE (3,085)
VINCRISTINE (2,940)
OXALIPLATIN (2,886)
Which TECLISTAMAB-CQYV Alternatives Have Lower Thrombocytopenia Risk?
TECLISTAMAB-CQYV vs TEDIZOLID
TECLISTAMAB-CQYV vs TEDUGLUTIDE
TECLISTAMAB-CQYV vs TEDUGLUTIDE\WATER
TECLISTAMAB-CQYV vs TEGAFUR
TECLISTAMAB-CQYV vs TEGAFUR\URACIL